MEI Pharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US55279B3015
USD
1.75
-0.05 (-2.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
Jun'18
Net Sales
65.30
48.82
40.70
34.80
28.91
4.92
1.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
65.30
48.82
40.70
34.80
28.91
4.92
1.62
Raw Material Cost
0.38
1.81
1.24
1.41
2.67
4.26
3.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
22.91
30.52
29.30
24.41
16.72
14.60
9.79
Other Expenses
1.66
4.97
8.56
6.94
3.41
3.23
1.70
Total Expenditure (Excl Depreciation)
39.86
81.98
116.18
95.22
53.45
51.16
30.21
Operating Profit (PBDIT) excl Other Income
25.4
-33.199999999999996
-75.5
-60.4
-24.5
-46.2
-28.599999999999998
Other Income
3.24
3.32
0.28
1.00
1.40
1.79
-1.78
Operating Profit (PBDIT)
29.06
-28.03
-73.97
-59.14
-23.04
-44.37
-30.31
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-10.90
-2.00
20.75
18.12
-22.87
27.63
-9.71
Gross Profit (PBDT)
64.91
47.00
39.46
33.39
26.24
0.65
-1.76
Depreciation
0.38
1.81
1.24
0.28
0.11
0.08
0.05
Profit Before Tax
17.78
-31.84
-54.45
-41.31
-46.02
-16.82
-40.07
Tax
0.00
0.00
0.00
0.01
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.78
-31.84
-54.45
-41.31
-46.02
-16.82
-40.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.78
-31.84
-54.45
-41.31
-46.02
-16.82
-40.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.78
-31.84
-54.45
-41.31
-46.02
-16.82
-40.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
33.02
24.62
52.41
49.47
78.22
47.93
50.46
Earnings per share (EPS)
2.67
-4.78
-9.99
-12.0
-10.1
-15.09
-19.4
Diluted Earnings per share
2.67
-4.78
-9.99
-12.0
-10.1
-15.09
-19.4
Operating Profit Margin (Excl OI)
38.96%
-67.94%
-185.48%
-173.65%
-84.88%
-940.9%
-1762.39%
Gross Profit Margin
27.81%
-61.5%
-130.77%
-117.89%
-158.77%
-340.55%
-2466.95%
PAT Margin
27.23%
-65.22%
-133.8%
-118.73%
-159.15%
-342.2%
-2470.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2024 is 33.81% vs 19.90% in Jun 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Jun 2024 is 155.97% vs 41.65% in Jun 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2024 is 182.43% vs 57.82% in Jun 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Jun 2024 has improved from Jun 2023

Compare Annual Results Of MEI Pharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
65.30
0.00
65.30
Other Operating Income
0.00
0.00
0.00
Total Operating income
65.30
0.00
65.30
Raw Material Cost
0.38
0.02
0.36
1,800.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
4.56
-4.56
-100.00%
Selling and Distribution Expenses
22.91
9.93
12.98
130.72%
Other Expenses
1.66
0.73
0.93
127.40%
Total Expenditure (Excl Depreciation)
39.86
21.85
18.01
82.43%
Operating Profit (PBDIT) excl Other Income
25.44
-21.85
47.29
216.43%
Other Income
3.24
27.85
-24.61
-88.37%
Operating Profit (PBDIT)
29.06
6.02
23.04
382.72%
Interest
0.00
4.56
-4.56
-100.00%
Exceptional Items
-10.90
0.00
-10.90
Gross Profit (PBDT)
64.91
-0.02
64.93
324,650.00%
Depreciation
0.38
0.02
0.36
1,800.00%
Profit Before Tax
17.78
1.44
16.34
1,134.72%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
17.78
1.44
16.34
1,134.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.78
1.44
16.34
1,134.72%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.78
1.44
16.34
1,134.72%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
33.02
-25.69
58.71
228.53%
Earnings per share (EPS)
2.67
0.19
2.48
1,305.26%
Diluted Earnings per share
2.67
0.19
2.48
1,305.26%
Operating Profit Margin (Excl OI)
38.96%
0.00%
0.00
38.96%
Gross Profit Margin
27.81%
0.00%
0.00
27.81%
PAT Margin
27.23%
0.00%
0.00
27.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6.53 Million
in Jun 2024

Figures in Million
stock-summary

YoY Growth in year ended Jun 2024 is 33.81% vs 19.90% in Jun 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 1.78 Million
in Jun 2024

Figures in Million
stock-summary

YoY Growth in year ended Jun 2024 is 155.97% vs 41.65% in Jun 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.58 Million
in Jun 2024

Figures in Million
stock-summary

YoY Growth in year ended Jun 2024 is 182.43% vs 57.82% in Jun 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.96%
in Jun 2024

Figures in %
stock-summary

YoY Growth in year ended Jun 2024 has improved from Jun 2023